Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ImmunoCellular Therapeutics
ImmunoCellular Therapeutics
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
Minyanville
Tue, 06/18/13 - 11:53 am
immunotherapy
Celldex
OncoSec
ImmunoCellular Therapeutics
Northwest Biotherapeutics
3 Biotech Stocks With Potential
Seeking Alpha
Tue, 05/14/13 - 10:13 am
Keryx
NeoStem
ImmunoCellular Therapeutics
Sarepta
Undervaluation Of Vical's Full Pipeline Allows A Cheap Bet On Cancer Trial
Seeking Alpha
Fri, 05/3/13 - 12:57 pm
Vical
Amgen
Bristol-Myers Squibb
OncoSec
ImmunoCellular Therapeutics
Roche
NCT00395070
melanoma
ImmunoCellular Therapeutics: A Close Look At Key Issues For The Ongoing Phase II Trial Of ICT-107
Seeking Alpha
Wed, 03/27/13 - 12:00 pm
ImmunoCellular Therapeutics
Dendreon
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics Reports Third Quarter 2012 Financial Results
Mon, 11/12/12 - 10:56 pm
ImmunoCellular Therapeutics
earnings
ImmunoCellular Therapeutics, Ltd. Announces Pricing of its Previously Announced Public Offering of Common Stock and Warrants
Thu, 10/18/12 - 10:47 pm
ImmunoCellular Therapeutics
stock
ImmunoCellular Therapeutics Completes Enrollment of Phase II Trial of ICT-107 in Glioblastoma
Wed, 09/5/12 - 09:45 pm
ImmunoCellular Therapeutics
clinical trials
ImmunoCellular CEO Steps Down But Leaves Company Well Positioned
Seeking Alpha
Tue, 08/21/12 - 11:32 am
ImmunoCellular Therapeutics
Dendreon
Jazz Pharmaceuticals
Merck
Verastem
Roche
Oncothyreon
ImmunoCellular Therapeutics Appoints John S. Yu, MD, as Interim Chief Executive Officer
Mon, 08/20/12 - 11:02 pm
Management
ImmunoCellular Therapeutics
ImmunoCellular Therapeutics Reports Second Quarter Results
Wed, 08/15/12 - 09:30 pm
ImmunoCellular Therapeutics
earnings
ImmunoCellular Therapeutics’ ICT-107 featured on CNN’s Sanjay Gupta MD
Mon, 08/13/12 - 08:46 pm
ImmunoCellular Therapeutics
CNN
ImmunoCellular Therapeutics’ Data From Phase I Trial of ICT-107 Accepted for Publication in Prestigious Medical Journal, Cancer Immunology, Immunotherapy
Thu, 08/9/12 - 12:44 am
ImmunoCellular Therapeutics
data
clinical trials
ImmunoCellular Therapeutics: Explaining The Benefits Of A Multiple Antigen Targeting Approach
Seeking Alpha
Mon, 07/23/12 - 08:56 am
ImmunoCellular Therapeutics
glioblastoma
ICT-107
ImmunoCellular Therapeutics Will Benefit As FDA Speeds Up Approval Process
Seeking Alpha
Thu, 07/19/12 - 07:47 am
ImmunoCellular Therapeutics
drug approvals
FDA
Celldex
Dendreon
Jazz Pharmaceuticals
Questcor
Sunesis
Threshold Pharmaceuticals
Spectrum Pharmaceuticals
ImmunoCellular provides update on Phase II clinical trial of ICT-107
Mon, 07/2/12 - 03:54 pm
ImmunoCellular Therapeutics
clinical trials
ImmunoCellular: Cancer Is Smart, But Could An Experimental Cancer Vaccine Be Smarter?
Wed, 06/27/12 - 10:11 pm
ImmunoCellular Therapeutics
cancer
vaccine
ImmunoCellular to be added to Russell 3000
Mon, 06/18/12 - 10:59 pm
ImmunoCellular Therapeutics
Russell
ImmunoCellular and Synta Pharmaceuticals Strong Performers in a Booming Industry
Tue, 06/5/12 - 10:18 pm
ImmunoCellular Therapeutics
Synta Pharmaceuticals
industry
ImmunoCellular Therapeutics Receives Approval for NYSE MKT Listing
Mon, 05/28/12 - 10:13 am
ImmunoCellular Therapeutics
stock
ImmunoCellular Provides an Update on Enrollment for the Company’s Phase II Clinical Trial
Wed, 05/9/12 - 10:23 pm
ImmunoCellular Therapeutics
clinical trial
Pages
« first
‹ previous
1
2
3
4
next ›
last »